title: [Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
authors.affiliation: Unités de pharmacologie et de pharmacocinétique cliniques, centre Claudius-Regaud, Toulouse, France.
authors.forename: E
authors.initials: E
authors.lastname: Chatelut
authors.forename: P
authors.initials: P
authors.lastname: Canal
authors.forename: M
authors.initials: M
authors.lastname: De Forni
authors.forename: C
authors.initials: C
authors.lastname: Chevreau
authors.forename: G
authors.initials: G
authors.lastname: Houin
authors.forename: R
authors.initials: R
authors.lastname: Bugat
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D013713:Teniposide; D011034:Podophyllotoxin; D002945:Cisplatin
vernacular_title: Essai de phase I et pharmacocinetique du VM26 associé au cisplatine par voie intrapéritoneale sans temps de "barbotage" (dwell time).